BusStim-LLC-logo
Dereck D Amakye MBChB DCH FFPM
Oncologist
Extensive pharmaceutical industry experience, with ~20 years in Oncology drug development, spanning translational medicine through late-stage development and life-cycle management. Completed Medical Specialty Training in Pharmaceutical Medicine (Certified Specialist, UK) and Fellow of the Faculty of Pharmaceutical Medicine (FFPM) of Royal Colleges of Physicians. Currently, working as an independent Oncology Drug Development Consultant at DDA Consultancy LLC.

Summary of Experiences:

Zentalis Pharmaceuticals, NY │Senior Vice-President, Clinical Development May 2023– Dec 2023

Bayer Pharmaceuticals, NJ │Vice-President & Head GMA Oncology Pipeline Jun 2017– Apr 2023

Bayer Pharmaceuticals, NJ │Head of GMA Oncology Pipeline

Novartis Institute of Biomedical Research │Global Clinical Program Leader May 2009 –Jan 2011

AstraZeneca Oncology, UK │Global Brand Physician, Clinical Development   Apr 2007 –Apr 2009

AstraZeneca Oncology │Oncology Research Physician, Discovery Medicine Apr 2004 –Mar 2007

Covance Clinical Research Unit, UK │Medical Director Jun 2002 – Mar 2004

Highlight Achievements:

• Investigator for ~ 300 phase 1 studies in healthy volunteers over a 6.5-year period at Covance CRU.

• Contributed to the development of many agents, which are now approved and marketed drugs, such as: Nplate (Amgen), for treating idiopathic thrombocytopenic purpura; Ramelteon (Takeda), for treating insomnia; Udenafil (Daichii), a phosphodieterase 5 inhibitor, for erectile dysfunction; Exenatide (AstraZeneca) for diabetes mellitus; Tekturna (aliskiren, Novartis), a rennin antagonist, for treating hypertension; Tadalafil (Cialis, Lilly) for erectile dysfunction; Artemether-lumefantrine (Coartem, Novartis) for treating malaria; and Sonidegib (Odomzo, Sun Pharma [Novartis]) for the treatment of locally advance or recurrent BCC.

• Honorary Lecturer, University of Leeds (1998-2003) for Certificate in Clinical Research course.

Education and Professional Qualifications

• Executive Management Education @ Harvard Business School: Strategic Agility, September 13-24, 2021.

• Executive Management Education @Harvard Business School: Disruptive Innovation, July 9-14, 2018.

• General Medical Council (UK) Registration

Limited Registration: June 1993 to June 1997

Full Registration (Principal List): since 11 June 1997

• Specialist Register (Pharmaceutical Medicine): since 22 August 2008

• Elected Fellow, Faculty of Pharmaceutical Medicine (FFPM, June 2008)

• Completed Specialist Training in Pharmaceutical Medicine (UK, Jan 2008)

• Diploma in Pharmaceutical Medicine (UK, 2000)

• Completed Modular course in Pharmaceutical Medicine, University of Wales, UK (2000)

• Diploma in Child Health (DCH), Royal College of Paediatrics & Child Health (UK, 1997)

• MB ChB, University of Ghana Medical School (1985-1991)

• President, Ghana Medical Students’ Association (1989/90)

• Presby. Boys’ Sixth Form Science College, Legon, Ghana (1982-1984); GCE Advanced Level:

Mathematics (A), Chemistry (A) and Physics (A)

Other team members

Share by: